|
|
||||||||
Ann Thorac Surg 2000;69:314
© 2000 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, Niigata University School of Medicine, 1-757 Asahimachi-dori, Niigata City 951-8510, Japan
e-mail: mtsuchi{at}med.niigata-u.ac.jp
To the Editor
We appreciate the opportunity to reply to the comments by Dr Kirschner concerning our article [1].
As pointed out by Dr Kirschner, myasthenia gravis (MG) patients comprise a wide and heterogeneous population, even with respect to the pathology of thymus. Thus, the patients background should be considered when comparing the efficacy of treatment.
When we compared the young and elderly groups in our series, there were no statistically significant differences with respect to several parameters, including gender, Osserman classification, and pathology of the thymus. Furthermore, according to gender, 6 of the 10 males (60%) and 4 of the 15 females (27%) in the elderly group had thymoma, which is comparable with the young group, in which thymoma was present in 10 of the 18 males (56%) and 12 of the 51 females (24%). Thus, we did not encounter the same demographic distribution of thymomatous and nonthymomatous MG patients as reported by Compston and associates [2]. Recent reports have also indicated an increase in late-onset MG with no evidence of a relationship between thymoma and age [3, 4]. However, we did note gender differences with respect to Osserman classification between nonthymoma and thymoma elderly patients, such that there were more women who tended to have a lower Osserman classification (IIA) among nonthymomatous patients. On the other hand, thymomatous patients tended to comprise more men, with a more severe Osserman classification (IIB). It is also of note that the surgical results did not differ remarkably between nonthymomatous and thymomatous patients; 14 improved (including 2 delayed deaths) and 1 worsened among the 15 nonthymomatous patients. Among the 10 thymomatous patients, 2 went into remission and 6 showed improvement. Extended thymectomy in thymomatous patients refers to excision of the entire anterior mediastinal fatty tissue including the thymus and thymoma. In our series, thymoma is defined as a tumor composed of neoplastic epithelial cells and lymphocytes, and does not include thymic carcinoma, thymic carcinoid, or thymolipoma. In addition, we did not observe a rise in the titers of acetylcholine receptor antibodies after extended thymectomy for thymomatous myasthenia gravis. In summary, we reexamined our results from a different point of view based on Kirschners comments by dividing elderly patients into thymomatous and nonthymomatous myasthenia gravis patients. Despite these modifications, we still came to the conclusion that surgery is indicated for both nonthymomatous and thymomatous elderly patients. We thank Dr Kirschner for his comments.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |